Zosano Pharma Corp Accretion Expense
Zosano Pharma Corp reported Accretion Expense of $112.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2016-05-12
- Zosano Pharma Corp accretion expense for the quarter ending 2016-03-31 was $112.00K, a 68.09% decline year-over-year.
- Zosano Pharma Corp accretion expense for the quarter ending 2015-06-30 was -$375.00K, a 199.73% decline year-over-year.
- Zosano Pharma Corp accretion expense for the quarter ending 2015-03-31 was $351.00K, a 17.79% increase year-over-year.
- Zosano Pharma Corp accretion expense for the quarter ending 2014-06-30 was $376.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month |
|---|---|---|
| 2016-03-31 | $112.00K 10-Q · filed 2016-05-12 | |
| 2015-06-30 | -$375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$24.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $351.00K 10-Q · filed 2016-05-12 | |
| 2014-06-30 | $376.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $674.00K 10-Q · filed 2015-08-13 |
| 2014-03-31 | $298.00K 10-Q · filed 2015-05-12 |